HomeInsightsStock Comparison

Alivus Life Sciences Ltd vs Mono Pharmacare Ltd Stock Comparison

Alivus Life Sciences Ltd vs Mono Pharmacare Ltd Stock Comparison

Last Updated on: Jun 05, 2025

Key Highlights

  • The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 1017 as of 05 Jun 09:33.
  • The P/E Ratio of Alivus Life Sciences Ltd is 0 as of March 2023 .The P/E Ratio of Mono Pharmacare Ltd is 0 as of March 2023.
  • The Market Cap of Alivus Life Sciences Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Mono Pharmacare Ltd is ₹ 0 crore as of March 2023.
  • The revenue of Alivus Life Sciences Ltd for the Mar '25 is ₹ 659.63 crore as compare to the Dec '24 revenue of ₹ 652.3 crore. This represent the growth of 1.12% The revenue of Mono Pharmacare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Alivus Life Sciences Ltd for the Mar '25 is ₹ 208.52 crore as compare to the Dec '24 ebitda of ₹ 200.76 crore. This represent the growth of 3.87% The ebitda of Mono Pharmacare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Alivus Life Sciences Ltd changed from ₹ 135.45 crore to ₹ 141.87 crore over 8 quarters. This represents a CAGR of 2.34% The net profit of Mono Pharmacare Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 58.56 % on March 2024 . This represents a CAGR of -1.60% over 3 yearsThe Dividend Payout of Mono Pharmacare Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alivus Life Sciences Ltd

  • Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018.
  • A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited.
  • The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.

About Mono Pharmacare Ltd

  • Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
  • Mono Chemist' through Partnership Deed dated May 06, 1994.
  • The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad.
  • The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners.

Alivus Life Sciences Ltd News Hub

News

Board of Alivus Life Sciences recommends final dividend

Alivus Life Sciences announced that the Board of Directors of the Company at its meeting h...

Read more

16 May 2025 09:27

News

Alivus Life Sciences to hold board meeting

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

09 May 2025 10:57

News

Alivus Life Sciences allots 92,096 equity shares under ESOS

Alivus Life Sciences has allotted 92,096 equity shares under ESOS on 30 April 2025. Conseq...

Read more

30 Apr 2025 19:38

News

Alivus Life jumps after Q3 PAT climbs 15% YoY to Rs 137 cr

Profit before tax (PBT) climbed 15.22% YoY to Rs 185.14 crore in Q3 FY25. For Q3FY25, EBIT...

Read more

23 Jan 2025 15:01

News

Alivus Life Sciences Ltd leads gainers in 'A' group

Avantel Ltd, Sunteck Realty Ltd, Spandana Sphoorty Financial Ltd and Jai Corp Ltd are amon...

Read more

21 Jan 2025 12:00

News

Glenmark Life Sciences renamed as Alivus Life Sciences

Glenmark Life Sciences announced its change of identity to Alivus Life Sciences, marking a...

Read more

20 Jan 2025 10:18

Mono Pharmacare Ltd News Hub

News

Mono Pharmacare to conduct board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 28 May 202...

Read more

13 May 2025 16:38

News

Mono Pharmacare announces board meeting date

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 April 2...

Read more

05 Apr 2025 14:35

News

Mono Pharmacare to hold board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 2 April 20...

Read more

29 Mar 2025 09:47

News

Mono Pharmacare to convene board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 10 Februar...

Read more

03 Feb 2025 10:50

News

Mono Pharmacare announces board meeting date

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 January...

Read more

04 Jan 2025 10:27

News

Mono Pharmacare to convene board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 14 Novembe...

Read more

07 Nov 2024 15:32

SWOT Analysis Of Mono Pharmacare Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Alivus Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Mono Pharmacare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alivus Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alivus Life Sciences Ltd and Mono Pharmacare Ltd

Which company has a larger market capitalization, Alivus Life Sciences Ltd or Mono Pharmacare Ltd?

Market cap of Alivus Life Sciences Ltd is 12,560 Cr while Market cap of Mono Pharmacare Ltd is 42 Cr

What are the key factors driving the stock performance of Alivus Life Sciences Ltd and Mono Pharmacare Ltd?

The stock performance of Alivus Life Sciences Ltd and Mono Pharmacare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alivus Life Sciences Ltd and Mono Pharmacare Ltd?

As of June 5, 2025, the Alivus Life Sciences Ltd stock price is INR ₹1024.25. On the other hand, Mono Pharmacare Ltd stock price is INR ₹24.25.

How do dividend payouts of Alivus Life Sciences Ltd and Mono Pharmacare Ltd compare?

To compare the dividend payouts of Alivus Life Sciences Ltd and Mono Pharmacare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions